1. Home
  2. RCMT vs ELTX Comparison

RCMT vs ELTX Comparison

Compare RCMT & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCMT
  • ELTX
  • Stock Information
  • Founded
  • RCMT 1971
  • ELTX 2011
  • Country
  • RCMT United States
  • ELTX United States
  • Employees
  • RCMT N/A
  • ELTX N/A
  • Industry
  • RCMT Professional Services
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCMT Consumer Discretionary
  • ELTX Health Care
  • Exchange
  • RCMT Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • RCMT 133.5M
  • ELTX 121.7M
  • IPO Year
  • RCMT N/A
  • ELTX N/A
  • Fundamental
  • Price
  • RCMT $22.14
  • ELTX $8.05
  • Analyst Decision
  • RCMT Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • RCMT 2
  • ELTX 2
  • Target Price
  • RCMT $33.50
  • ELTX $9.50
  • AVG Volume (30 Days)
  • RCMT 33.1K
  • ELTX 51.5K
  • Earning Date
  • RCMT 08-06-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • RCMT N/A
  • ELTX N/A
  • EPS Growth
  • RCMT N/A
  • ELTX N/A
  • EPS
  • RCMT 1.74
  • ELTX N/A
  • Revenue
  • RCMT $290,914,000.00
  • ELTX N/A
  • Revenue This Year
  • RCMT $16.29
  • ELTX N/A
  • Revenue Next Year
  • RCMT $6.16
  • ELTX N/A
  • P/E Ratio
  • RCMT $13.10
  • ELTX N/A
  • Revenue Growth
  • RCMT 8.53
  • ELTX N/A
  • 52 Week Low
  • RCMT $13.18
  • ELTX $3.34
  • 52 Week High
  • RCMT $26.37
  • ELTX $9.99
  • Technical
  • Relative Strength Index (RSI)
  • RCMT 50.52
  • ELTX 63.45
  • Support Level
  • RCMT $22.02
  • ELTX $7.76
  • Resistance Level
  • RCMT $23.15
  • ELTX $8.10
  • Average True Range (ATR)
  • RCMT 0.67
  • ELTX 0.60
  • MACD
  • RCMT -0.24
  • ELTX -0.03
  • Stochastic Oscillator
  • RCMT 7.72
  • ELTX 54.76

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: